It has been suggested that sFas could provide apoptosis resistance through an autocrine manner with tumor-derived sFasL exerting a paracrine pro-apoptotic effect in the microenvironment of pancreatic cancers [25]. This evidence concerns the gene FASLG and pancreatic neoplasm.